| Financial Year |
March 31 2023 |
| Monetary Funds |
207,646,952.84 |
| Held-for-trading Financial Assets |
30,017,835.61 |
| Notes Receivable |
10,304,336.60 |
| Accounts Receivable |
310,231,441.46 |
| Advances to Suppliers |
7,061,228.36 |
| Other Receivables |
6,238,889.57 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
172,272,441.96 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
627,643.47 |
| Total Current Assets |
755,666,296.24 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
20,884,956.91 |
| Investment Properties |
-- |
| Fixed Assetes |
254,621,813.35 |
| Under-construction Projects |
14,651,431.81 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
69,197,905.60 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
14,187,711.84 |
| Deferred Income Tax Assets |
4,569,556.85 |
| Other Non-Current Assets |
7,321,076.62 |
| Sub-Total of Non-Current Assets |
390,024,900.55 |
| Total Assets |
1,145,691,196.79 |
| Short-Term Loans |
65,957,238.60 |
| Trading Financial liabilities |
-- |
| Notes Payable |
13,258,190.68 |
| Accounts Payable |
157,428,390.24 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
19,733,973.08 |
| Taxes Payable |
15,310,602.72 |
| Interest Payable |
-- |
| Dividend Payable |
12,731,593.92 |
| Other payables |
15,172,340.19 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,037,456.19 |
| Other Current Liabilities |
10,102,059.70 |
| Sub-Total of Current Liabilities |
298,996,555.38 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,347,836.11 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,448,386.29 |
| Total Liabilities |
303,444,941.67 |
| Paid-In Capital(Or Share Stock) |
106,096,616.00 |
| Capital Surplus |
488,824,698.45 |
| Surplus Reserve |
21,827,660.52 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
225,497,280.15 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
842,246,255.12 |
| Owner's Equity（Stockholder's Equity） |
842,246,255.12 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,145,691,196.79 |
